sq-11725 has been researched along with Glaucoma, Suspect in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Krieglstein, GK; Mohamed, J | 1 |
Duzman, E; Lazar, M; Rosen, N | 1 |
Anderson, J; Blumenthal, M; Chen, CC; Duzman, E; Twizer, H | 1 |
3 trial(s) available for sq-11725 and Glaucoma, Suspect
Article | Year |
---|---|
The comparative multiple-dose intraocular pressure responses of nadolol and timolol in glaucoma and ocular hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Clinical Trials as Topic; Glaucoma; Humans; Intraocular Pressure; Middle Aged; Nadolol; Ocular Hypertension; Propanolamines; Timolol | 1982 |
Diacetyl nadolol: 3-month ocular hypotensive effect in glaucomatous eyes.
Topics: Adrenergic beta-Antagonists; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Nadolol; Ocular Hypertension; Propanolamines; Timolol | 1983 |
Diacetyl derivative of nadolol. I. Ocular pharmacology and short-term ocular hypotensive effect in glaucomatous eyes.
Topics: Absorption; Adult; Animals; Clinical Trials as Topic; Double-Blind Method; Eye; Female; Glaucoma, Open-Angle; Humans; Hydrolysis; Male; Nadolol; Ocular Hypertension; Propanolamines; Rabbits; Timolol | 1982 |